Lexeo Therapeutics (LXEO) Operating Profit

Annual Operating Profit

-$68.51 M
-$8.00 M-13.23%

December 31, 2023


Summary


Performance

LXEO Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLXEOprofitabilitymetrics:

Quarterly Operating Profit

-$31.54 M
-$7.99 M-33.94%

September 30, 2024


Summary


Performance

LXEO Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLXEOprofitabilitymetrics:

TTM Operating Profit

-$93.36 M
-$11.27 M-13.73%

September 30, 2024


Summary


Performance

LXEO TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLXEOprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

LXEO Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.2%-55.6%-35.8%
3 y3 years-1393.4%-55.6%-35.8%
5 y5 years-1393.4%-55.6%-35.8%

LXEO Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.3%at low-125.7%at low-509.7%at low
5 y5-year-1393.4%at low-125.7%at low-509.7%at low
alltimeall time-1393.4%at low-125.7%at low-509.7%at low

Lexeo Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$31.54 M(+33.9%)
-$93.36 M(+13.7%)
Jun 2024
-
-$23.55 M(+1.1%)
-$82.09 M(+13.2%)
Mar 2024
-
-$23.29 M(+55.5%)
-$72.51 M(+5.8%)
Dec 2023
-$68.51 M
-$14.97 M(-26.1%)
-$68.51 M(-0.3%)
Sep 2023
-
-$20.27 M(+45.1%)
-$68.73 M(+4.2%)
Jun 2023
-
-$13.97 M(-27.6%)
-$65.94 M(-2.0%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$19.29 M(+26.9%)
-$67.28 M(+40.2%)
Dec 2022
-$60.51 M(+19.5%)
-$15.20 M(-13.1%)
-$47.99 M(+46.3%)
Sep 2022
-
-$17.48 M(+14.2%)
-$32.79 M(+114.2%)
Jun 2022
-
-$15.31 M
-$15.31 M
Dec 2021
-$50.64 M(+1003.7%)
-
-
Dec 2020
-$4.59 M
-
-

FAQ

  • What is Lexeo Therapeutics annual operating income?
  • What is the all time high annual operating profit for Lexeo Therapeutics?
  • What is Lexeo Therapeutics annual operating profit year-on-year change?
  • What is Lexeo Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Lexeo Therapeutics?
  • What is Lexeo Therapeutics quarterly operating profit year-on-year change?
  • What is Lexeo Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Lexeo Therapeutics?
  • What is Lexeo Therapeutics TTM operating profit year-on-year change?

What is Lexeo Therapeutics annual operating income?

The current annual operating profit of LXEO is -$68.51 M

What is the all time high annual operating profit for Lexeo Therapeutics?

Lexeo Therapeutics all-time high annual operating income is -$4.59 M

What is Lexeo Therapeutics annual operating profit year-on-year change?

Over the past year, LXEO annual operating income has changed by -$8.00 M (-13.23%)

What is Lexeo Therapeutics quarterly operating income?

The current quarterly operating profit of LXEO is -$31.54 M

What is the all time high quarterly operating profit for Lexeo Therapeutics?

Lexeo Therapeutics all-time high quarterly operating income is -$13.97 M

What is Lexeo Therapeutics quarterly operating profit year-on-year change?

Over the past year, LXEO quarterly operating income has changed by -$11.27 M (-55.59%)

What is Lexeo Therapeutics TTM operating income?

The current TTM operating profit of LXEO is -$93.36 M

What is the all time high TTM operating profit for Lexeo Therapeutics?

Lexeo Therapeutics all-time high TTM operating income is -$15.31 M

What is Lexeo Therapeutics TTM operating profit year-on-year change?

Over the past year, LXEO TTM operating income has changed by -$24.62 M (-35.82%)